Diagnostic News and Research

RSS

People with chronic fatigue syndrome could experience higher levels of visual stress

People suffering from Chronic Fatigue Syndrome (CFS) could experience higher levels of visual stress than those without the condition, according to new research from the University of Leicester.

25 Nov 2015

Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition

Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will introduce its CMOS X-Ray detector for mammography at the RSNA 2015 Technical Exhibition, November 29 to December 3, at McCormick Place in Chicago.

24 Nov 2015

Sound Physicians agrees to provide hospitalist services for Mount Vernon's Skagit Valley Hospital

Sound Physicians, a health care organization focused on improving quality and lowering cost throughout the acute episode of care, announced today an agreement to provide hospitalist services for Skagit Valley Hospital in Mount Vernon, WA.

24 Nov 2015

BioPlast Manufacturing acquires Kord-Valmark

BioPlast Manufacturing, a manufacturer of plastic components used primarily for the medical research, clinical diagnostic and biotech environments, announced today that it has acquired Kord-Valmark, a leading manufacturer of quality petri dishes. This acquisition is aligned with BioPlast Manufacturing's strategy to offer clients a platform of products that are designed and tested by scientists for scientists and manufactured with the highest quality.

24 Nov 2015

Findings could offer doctors new method to diagnose pancreatic cancer earlier in patients

By collecting samples from the portal vein--which carries blood from the gastrointestinal tract, including from the pancreas, to the liver--physicians can learn far more about a patient's pancreatic cancer than by relying on peripheral blood from a more easily accessed vein in the arm.

23 Nov 2015

ADMT withdraws Premarket Notification 510(k) application for Angiodroid Injector

ADM Tronics Unlimited, Inc. has announced that Angiodroid America, Inc. has withdrawn its Premarket Notification 510(k) application filed with the US Food and Drug Administration for Angiodroid The CO2 Injector for Angiography (the "Angiodroid Injector").

22 Nov 2015

WSU researchers establish categorical distinction between heterosexuals and non-heterosexuals

Washington State University researchers have established a categorical distinction between people who are heterosexual and those who are not. By analyzing the reported sexual behavior, identity and attraction of more than 33,000 American adults, they found that 3 percent of men and 2.7 percent of women are not heterosexual. They also found notable issues on several mental health fronts.

20 Nov 2015

Modest physical activity associated with lower risk of cardiovascular disease in older adults

In a large prospective community-based study of older Americans, modest physical activity was associated with a lower risk of cardiovascular disease (CVD). This was true even among men and women older than age 75 at baseline - a rapidly growing population for whom regular activity has been advised, but with little supportive empirical evidence.

19 Nov 2015

Role of biomarkers in drug development and regulatory decision making

Biomarkers in Medicine, a leading MEDLINE-indexed journal, has published a special focus issue exploring the increasingly important role of biomarkers in both drug development and regulatory decision making.

19 Nov 2015

NIH-led collaboration details research strategy to address brain disorders

Infants are starved of oxygen during difficult births. Children's cognitive function is permanently damaged due to malnutrition or exposure to infections or toxins. Adults suffer from crippling depression or dementia. The breadth and complexity of these and other brain and nervous system disorders make them some of the most difficult conditions to diagnose and treat, especially in the developing world, where there are few resources.

19 Nov 2015

Apollo to demonstrate integration with ResolutionMD at RSNA annual meeting

Apollo, the pioneer in clinical multimedia management solutions is introducing, and will be demonstrating integration of the ResolutionMD enterprise image viewer to Apollo EPMM (Enterprise Patient Multimedia Manager) at the upcoming RSNA 2015 annual meeting. This is a result of a previously announced alliance between Apollo and Calgary Scientific.

18 Nov 2015

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

A simple, ultrasensitive microRNA sensor developed and tested by researchers from the schools of science and medicine at Indiana University-Purdue University Indianapolis and the Indiana University Melvin and Bren Simon Cancer Center holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.

18 Nov 2015

HITLAB selects five finalists for HITLAB World Cup

HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.

17 Nov 2015

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.

17 Nov 2015

AstraZeneca announces FDA approval of TAGRISSO (AZD9291) for treatment of lung cancer patients

AstraZeneca today announced that the US Food and Drug Administration has approved TAGRISSO (AZD9291) 80mg once-daily tablets for the treatment of patients with metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small cell lung cancer (NSCLC), as detected by an FDA-approved test, who have progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.

17 Nov 2015

Myriad RBM's DiscoveryMAP platform identifies protein biomarkers linked to CV events in diabetes patients

Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that its DiscoveryMAP platform successfully identified combinations of 15 protein biomarkers associated with cardiovascular (CV) events or death in people with pre-diabetes or early type 2 diabetes, according to a study published by the journal Circulation.

17 Nov 2015

Augmented microscopy may allow neurosurgeons to clearly distinguish cancerous from healthy tissue

Researchers at the University of Arizona have invented a device that for the first time allows neurosurgeons, who use microscopes extensively while operating, to see blood flowing inside vessels and more clearly distinguish cancerous from healthy tissue under the microscope.

17 Nov 2015

Haemodynamic variables may distinguish pre- from post-capillary PH

Researchers have identified the haemodynamic variables that best distinguish between patients with idiopathic pulmonary arterial hypertension and isolated post-capillary pulmonary hypertension.

16 Nov 2015

New tool may help diagnose and treat Parkinson's disease in early stages

A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society, have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson's disease, especially in its early stages.

15 Nov 2015

FDA grants accelerated approval for Tagrisso to treat patients with advanced NSCLC

Today, the U.S. Food and Drug Administration granted accelerated approval for an oral medication to treat patients with advanced non-small cell lung cancer (NSCLC). Tagrisso (osimertinib) is now approved for patients whose tumors have a specific epidermal growth factor receptor (EGFR) mutation (T790M) and whose disease has gotten worse after treatment with other EGFR-blocking therapy.

14 Nov 2015

Diagnostic News and Research

People with chronic fatigue syndrome could experience higher levels of visual stress

Teledyne DALSA's CMOS X-Ray detector for mammography to be introduced at RSNA 2015 Technical Exhibition

Sound Physicians agrees to provide hospitalist services for Mount Vernon's Skagit Valley Hospital

BioPlast Manufacturing acquires Kord-Valmark

Findings could offer doctors new method to diagnose pancreatic cancer earlier in patients

ADMT withdraws Premarket Notification 510(k) application for Angiodroid Injector

WSU researchers establish categorical distinction between heterosexuals and non-heterosexuals

Modest physical activity associated with lower risk of cardiovascular disease in older adults

Role of biomarkers in drug development and regulatory decision making

NIH-led collaboration details research strategy to address brain disorders

Apollo to demonstrate integration with ResolutionMD at RSNA annual meeting

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

HITLAB selects five finalists for HITLAB World Cup

Study may lead to development of highly accurate screening test for early-stage ovarian cancer

AstraZeneca announces FDA approval of TAGRISSO (AZD9291) for treatment of lung cancer patients

Myriad RBM's DiscoveryMAP platform identifies protein biomarkers linked to CV events in diabetes patients

Augmented microscopy may allow neurosurgeons to clearly distinguish cancerous from healthy tissue

Haemodynamic variables may distinguish pre- from post-capillary PH

New tool may help diagnose and treat Parkinson's disease in early stages

FDA grants accelerated approval for Tagrisso to treat patients with advanced NSCLC

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News